Clinical Trials Open to People Under 18
(70 trials open to new patients)

• Abortion (1 open to new patients)
• Acute Lymphoblastic Leukemia (1 open to new patients)
• Acute Myeloid Leukemia (1 open to new patients)
• Amyotropic Lateral Sclerosis (ALS) (1 open to new patients)
• Anemia (2 open to new patients)
• Ankylosing Spondylitis (1 open to new patients)
• Antiretroviral Toxicity (1 open to new patients)
• ATM Gene Mutation (1 open to new patients)
• Atopic Dermatitis (Eczema) (1 open to new patients)
• ATR Gene Mutation (1 open to new patients)
• Autism (2 open to new patients)
• Automimmune Diseases (1 open to new patients)
• Bacterial Infections (2 open to new patients)
• BARD1 Gene Mutation (1 open to new patients)
• Bipolar Disorder (1 open to new patients)
• Brain Tumor (2 open to new patients)
• BRCA 1 Gene Mutation (1 open to new patients)
• BRCA 2 Gene Mutation (1 open to new patients)
• BRIP1 Gene Mutation (1 open to new patients)
• Burns (1 open to new patients)
• Cancer, General (1 open to new patients)
• Cardiovascular Disease (1 open to new patients)
• Cerebrotendinous Xanthomatosis (CTX) (1 open to new patients)
• CHEK1 Gene Mutation (1 open to new patients)
• CHEK2 Gene Mutation (1 open to new patients)
• Cholestasis (1 open to new patients)
• Colorectal Cancer (1 open to new patients)
• Congenital Heart Disease (1 open to new patients)
• Creatine Deficiency, X-linked (1 open to new patients)
• Crohn's Disease (1 open to new patients)
• CTEPH (1 open to new patients)
• Cyanosis (1 open to new patients)
• Cyanotic Congenital Heart Disease (1 open to new patients)
• Cystinosis (1 open to new patients)
• Deletion and Duplication of Mitochondrial DNA (1 open to new patients)
• Dementia (1 open to new patients)
• Depression (1 open to new patients)
• Disorders of the Immune System (1 open to new patients)
• Duchenne Muscular Dystrophy (1 open to new patients)
• Eating Disorders (1 open to new patients)
• Eosinophilic Colitis (1 open to new patients)
• Eosinophilic Esophagitis (1 open to new patients)
• Eosinophilic Gastritis (1 open to new patients)
• Eosinophilic Gastrointestinal Disorders (EGIDs) (1 open to new patients)
• FANCA Gene Mutation (1 open to new patients)
• FANCC Gene Mutation (1 open to new patients)
• FANCD2 Gene Mutation (1 open to new patients)
• FANCF Gene Mutation (1 open to new patients)
• FANCM Gene Mutation (1 open to new patients)
• Fibrosing Colonopathy (1 open to new patients)
• Fibrosis (1 open to new patients)
• Fournier's Gangrene (1 open to new patients)
• Glioma (2 open to new patients)
• Hematologic Malignancies (1 open to new patients)
• Hemophilia (1 open to new patients)
• Hereditary Spastic Paraplegia (1 open to new patients)
• High Blood Pressure (1 open to new patients)
• Histiocytic Disorders (1 open to new patients)
• HIV/AIDS (4 open to new patients)
• Hodgkin's Lymphoma (1 open to new patients)
• Huntington's Disease (1 open to new patients)
• Hypertrophic Cardiomyopathy (1 open to new patients)
• Inflammatory Bowel Disease (2 open to new patients)
• Infusion Reactions (1 open to new patients)
• Inherited Abnormalities of Platelets (1 open to new patients)
• Inherited Disorders of Metabolism (1 open to new patients)
• Inherited Eye Disease (1 open to new patients)
• Irritable Bowel Syndrome (1 open to new patients)
• Juvenile Idiopathic Arthritis (1 open to new patients)
• Kawasaki Disease (1 open to new patients)
• Leukemia (1 open to new patients)
• Liver Disease (1 open to new patients)
• Long QT Syndrome (1 open to new patients)
• Lung Cancer (4 open to new patients)
• Lymphoma (1 open to new patients)
• MECP2 Duplication Syndrome (1 open to new patients)
• Medullary Thyroid Cancer (1 open to new patients)
• Mitochondrial Diseases (1 open to new patients)
• Mitochondrial Disorders (1 open to new patients)
• Mitochondrial Genetic Disorders (1 open to new patients)
• Mucocutaneous Lymph Node Syndrome (1 open to new patients)
• Multiple Myeloma (1 open to new patients)
• Multisystem Proteinopathy (1 open to new patients)
• NBN Gene Mutation (1 open to new patients)
• Necrotizing Fasciitis (1 open to new patients)
• Necrotizing Soft Tissue Infections (1 open to new patients)
• Neonatal Seizures (1 open to new patients)
• Neoplasms by Site (1 open to new patients)
• Nephrolithiasis (1 open to new patients)
• Nephropathic Cystinosis (1 open to new patients)
• NLRC4-MAS (1 open to new patients)
• Non Hodgkin Lymphoma (1 open to new patients)
• Obesity (4 open to new patients)
• Otomycosis (1 open to new patients)
• Outcomes (1 open to new patients)
• PALB2 Gene Mutation (1 open to new patients)
• Peripheral Arterial Disease (1 open to new patients)
• Pregnancy (2 open to new patients)
• Primary Lateral Sclerosis (1 open to new patients)
• Progressive Muscular Atrophy (1 open to new patients)
• Psoriasis (2 open to new patients)
• Psoriatic Arthritis (3 open to new patients)
• RAD51 Gene Mutation (1 open to new patients)
• RAD51B Gene Mutation (1 open to new patients)
• RAD54L Gene Mutation (1 open to new patients)
• Renal Fanconi Syndrome (1 open to new patients)
• Respiratory Syncytial Virus Infections (1 open to new patients)
• Retinopathy of Prematurity (1 open to new patients)
• Rett Syndrome (2 open to new patients)
• Rheumatoid Arthritis (1 open to new patients)
• RPA1 Gene Mutation (1 open to new patients)
• RTT-related Conditions (1 open to new patients)
• Sepsis (1 open to new patients)
• Sickle Cell Anemia (1 open to new patients)
• Solid Tumor (1 open to new patients)
• Suicide (1 open to new patients)
• Suicide, Attempted (1 open to new patients)
• Survival Rates (1 open to new patients)
• Thrombosis (1 open to new patients)
• Tuberculosis (1 open to new patients)
• Urinary Tract Infection (1 open to new patients)
• Urolithiasis (1 open to new patients)
• UTI (1 open to new patients)
• Venous Thrombosis (1 open to new patients)
• XIAP Deficiency (1 open to new patients)